AstraZeneca PLC on Monday said Enhertu reduced the risk of disease progression in a form of breast cancer. The Cambridge, England-based pharmaceutical company said Enhertu plus pertuzumab reduced the ...

AstraZeneca on Sunday said its monoclonal antibody Imfinzi in combination with standard of care chemotherapy demonstrated significant and meaningful improvement in event-free survival in early stage ...

After rapid expansion, signs of a slowdown raise questions about future opportunities in the sector When it emerged that ...

The firm is the first Newcastle University spinout to secure investment from Northern Gritstone, a fund that has to date ...

Partnership with Mace includes the installation of 108 laboratory fume cupboards Greater Manchester, UK – 8th April 2025 – Envair Technology, a leading specialist in clean air and containment ...